Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2005

01-06-2005 | Poster Presentation

Imprint as a reliable diagnostic tool in breast cancer and possible usefulness for research purposes

Authors: E Mortensen, L Hansen, JO Frantzen, S Klenow, N Bjurstam, RH Paulssen

Published in: Breast Cancer Research | Special Issue 2/2005

Login to get access

Excerpt

The aim in breast cancer treatment is to provide the correct diagnosis with minimal delay that makes it possible to immediately plan further treatment with the patient. In addition, the imprint method can be used to make a diagnosis on material that will be snap-frozen for future research purposes. …
Metadata
Title
Imprint as a reliable diagnostic tool in breast cancer and possible usefulness for research purposes
Authors
E Mortensen
L Hansen
JO Frantzen
S Klenow
N Bjurstam
RH Paulssen
Publication date
01-06-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1129

Other articles of this Special Issue 2/2005

Breast Cancer Research 2/2005 Go to the issue

Oral Presentation

Genetic and epigenetic changes in early carcinogenesis

Poster Presentation

DNA polymorphisms of several genes and predisposition to breast cancer

Poster Presentation

Identification of clinically relevant gene sets and pathways using functional models of breast tumor suppression

Oral Presentation

Evading p53 action during tumor development and therapy

Poster Presentation

Identification of drug targets for the treatment of Basal-like tumors

Poster Presentation

Gene expression profiling in breast cancer challenges the existence of intermediate histological grade
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits